Henry Schein | HSIC - Operating Profit


Henry Schein reported $193M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Agilent USD 444M 45M Jun/2026
Align Technology USD 193.04M 1.72M Sep/2026
Bruker USD 83.5M 13.9M Sep/2026
Cardinal Health USD 819M 5M Sep/2026
Charles River Laboratories USD 202.64M 82.75M Sep/2026
Cigna USD 2.4B 8M Sep/2026
Concord Medical Services Hldg CNY -94.68M 49.97M Dec/2025
Cooper Companies USD 222M 253M Jun/2026
CVS Health USD 3.57B 3.16B Sep/2026
Danaher USD 1.25B 118M Sep/2026
Dentsply International USD 38M 46M Sep/2026
Encompass Health USD 288M 400K Sep/2026
Henry Schein USD 193M 7M Sep/2026
Idexx Laboratories USD 402.35M 23.22M Sep/2026
IQVIA Holdings USD 608M 1.99B Sep/2026
Laboratory Of America USD 418M 38.7M Sep/2026
McKesson USD 1.69B 266M Sep/2026
Mettler Toledo International USD 287.55M 53.61M Jun/2026
Owens Minor USD 814K 28.08M Dec/2025
Quest Diagnostics USD 479M 20M Sep/2026
Revvity USD 124.63M 1.51M Sep/2026
Stryker USD 1.79B 687M Jun/2026
Tenet Healthcare USD 1.02B 354M Jun/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
Universal Health Services USD 454.45M 62.23M Sep/2026
Veradigm USD -45.47M 70.47M Dec/2022
Waters USD -86M 234M Jun/2026
Zimmer Biomet Holdings USD 341.5M 3.2M Sep/2026
Zoetis USD 1.03B 88M Sep/2026